Etoposide plus R-CVP for DLBCL patients who cannot be treated with anthracycline-based chemotherapy

Shoko Ishii

Presentation information

Oral Session

Oral Session 2-7B Aggressive Lymphoma: Clinical (2)

Sat. Oct 12, 2019 10:10 AM - 11:10 AM No.7 (Tokyo International Forum, 5F Hall D5)

Chair: Kazuyuki Shimada (Department of Hematology, Nagoya University Hospital)

[OS2-7B-4] Etoposide plus R-CVP for DLBCL patients who cannot be treated with anthracycline-based chemotherapy

Shoko Ishii¹, Yuko Shiota², Mamiko Momoki², Kurumi Tsukamoto², Hirofumi Yamauchi², Yutaro Kamiyama², Rie Ohba², Noriko Usui¹, Nobuaki Dobashi², Shingo Yano¹ (1.Hematol, Jikei Univ. Hospital, Tokyo, Japan, 2.Hematol, Jikei Univ. Daisan Hospital, Tokyo, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.